A tale of 'two worlds' for Novartis respiratory launches in U.S. and EU

Targeting different markets naturally requires using different marketing strategies. But for Novartis ($NVS), which is aiming to become a major respiratory player, its approaches within and outside the U.S. could end up being worlds apart. Report